Lifestyle

US FDA Puts Kezar Life Sciences' Lupus Treatment Trial on Hold After Patient Deaths

The U.S. Food and Drug Administration has placed a clinical hold on Kezar Life Sciences' trial of experimental drug for lupus, the company said on Friday.